Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Translational science in IBD

Written by | 9 Apr 2019

Dr Bram Verstockt (Leuven, Belgium) discusses a biopsy study looking at increases NCR+ ILC3 levels in IBD patients on biologic therapy.

IBD around the world

Written by | 9 Apr 2019

IBD is still mainly a phenomenon of the Western world, but the incidence is increasing steeply in newly industrialised countries where the population is undergoing rapid urbanisation…

Metabolic profiling

Written by | 13 Mar 2019

Metabolic interactions between the gut microbiome and its human host are thought to play a key role in the development of IBD and may hold the key to… read more.

VARSITY: head to head comparison of adalimumab vs vedolizumab in UC

Written by | 13 Mar 2019

The first-ever head-to-head comparative trial of two biological therapies in IBD indicates that UC patients treated with vedolizumab are significantly more likely to achieve remission than with adalimumab…. read more.

ECCO 2019 highlights

Written by | 11 Mar 2019

The sessions at ECCO 2019 were packed full of interesting data highlights and hot topics relevant to the treatment of IBD. In the video above, Professor Stefan Schreiber… read more.

ECCO 2018: Improving patient care in IBD

Written by | 7 Mar 2018

As a community IBD professionals are well aware of the need to raise the bar in terms of delivering quality care that maintains tight disease control and anticipates… read more.

ECCO 2018: Returning to a normal life with IBD

Written by | 1 Mar 2018

Even with access to more potent and sophisticated drugs than ever before, IBD professionals still have a long way to go in optimising treatment and alleviating the long-term… read more.

ECCO 2018: Evolving concepts of IBD pathogenesis

Written by | 1 Mar 2018

Perianal fistula is a debilitating complication in CD which affects up to 50% of patients in the course of their disease…

ECCO 2018: Novel treatments in IBD

Written by | 11 Feb 2018

The current research and development pipeline of novel biologic therapies and small molecule drugs promises improved efficacy and safety in the treatment of IBD in the near future…. read more.

ESCP Highlights 2017

Written by | 21 Oct 2017

ESCP 2017 delegates give their highlights, plus a report on the ESCP/ECCO symposium on ulcerative colitis and a focus on quality of life for patients with perianal Crohn’s disease.

ESCP 2017: Multidisciplinary decision-making for colectomy: the difficult patient 

Written by | 11 Oct 2017

By Maria Dalby (article) and Peter Mas Mollinedo (interviews) The decision to perform a colectomy in patients with ulcerative colitis (UC) should not be made lightly. Such a… read more.

Get involved in ECCO

Written by | 11 Apr 2017

Commentary and insights from Dr Filip Baert, (Roeselare, Belgium) and Usha Chauhan (McMaster University, Canada)  

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.